Five-Year Outcomes After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease
Authors:
- Patrick W. SerruysPSPatrick W. Serruys
- Andrew T.L. OngAOAndrew T.L. Ong
- Lex A. van HerwerdenLHLex A. van Herwerden
- J. Eduardo SousaJSJ. Eduardo Sousa
- Adib JateneAJAdib Jatene
- Johannes J.R.M. BonnierJBJohannes J.R.M. Bonnier
- Jacques P.M.A. SchönbergerJSJacques P.M.A. Schönberger
- Nigel BullerNBNigel Buller
- Robert BonserRBRobert Bonser
- Clemens DiscoCDClemens Disco
- Bianca BackxBBBianca Backx
- Paul G. HugenholtzPHPaul G. Hugenholtz
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomesJACC, 2003
- A decade of change—risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990–1999: a report from the STS National Database Committee and the Duke Clinical Research InstituteThe Annals of Thoracic Surgery, 2002
- Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel DiseaseNew England Journal of Medicine, 2001
- Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up resultsJACC, 2001
- The ARTS (Arterial Revascularization Therapies Study): Background, goals and methodsInternational Journal of Cardiovascular Interventions, 1999
- Estimation of a Common Effect Parameter from Sparse Follow-Up Data1985